UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 454

Sortiert nach

Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche

Cell stem cell, 2013-09, Vol.13 (3), p.285-299

2013

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva

British journal of clinical pharmacology, 2019-06, Vol.85 (6), p.1180-1187

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization

Orphanet journal of rare diseases, 2021-08, Vol.16 (1), p.1-350, Article 350

2021

Link zum Volltext

Verfügbarkeit prüfen

Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva

Bone (New York, N.Y.), 2018-04, Vol.109, p.162-167

2018

Link zum Volltext

Verfügbarkeit prüfen

Reduction of New Heterotopic Ossification (HO) in the Open‐Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP)

Journal of bone and mineral research, 2023-03, Vol.38 (3), p.381-394

2023

Link zum Volltext

Verfügbarkeit prüfen

A follow-up report on the published paper Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva

Orphanet journal of rare diseases, 2023-03, Vol.18 (1), p.61-61, Article 61

2023

Link zum Volltext

Verfügbarkeit prüfen

Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory

Nature neuroscience, 2015-03, Vol.18 (3), p.423-434

2015

Link zum Volltext

Verfügbarkeit prüfen

Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification

Current osteoporosis reports, 2019-12, Vol.17 (6), p.387-394

2019

Link zum Volltext

Verfügbarkeit prüfen

Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva

Orphanet journal of rare diseases, 2022-03, Vol.17 (1), p.107-107, Article 107

2022

Link zum Volltext

Verfügbarkeit prüfen

A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy

Calcified tissue international, 2023-08, Vol.113 (2), p.246-253

2023

Link zum Volltext

Verfügbarkeit prüfen

Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages

Nature communications, 2023-07, Vol.14 (1), p.3902-3902, Article 3902

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunologic Aspects in Fibrodysplasia Ossificans Progressiva

Biomolecules (Basel, Switzerland), 2024-03, Vol.14 (3), p.357

2024

Link zum Volltext

Verfügbarkeit prüfen

Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors

Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (26), p.10894-10899

2007

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA regulation of cell lineages in mouse and human embryonic stem cells

Cell stem cell, 2008-03, Vol.2 (3), p.219-229

2008

Link zum Volltext

Verfügbarkeit prüfen

BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence

Proceedings of the National Academy of Sciences - PNAS, 2016-11, Vol.113 (46), p.13057-13062

2016

Link zum Volltext

Verfügbarkeit prüfen

Improving care pathways for people living with rare bone diseases (RBDs): outcomes from the first RBD Summit

Osteoporosis international, 2023-08, Vol.34 (8), p.1301-1310

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of Risk Factors in the Development of Heterotopic Ossification after Primary Total Hip Arthroplasty

The journal of clinical endocrinology and metabolism, 2022-09, Vol.107 (9), p.e3944-e3952

2022

Link zum Volltext

Verfügbarkeit prüfen

Using Human Induced Pluripotent Stem Cells to Model Skeletal Diseases

Methods in molecular biology (Clifton, N.J.), 2016, Vol.1353, p.101

2016

Link zum Volltext

Verfügbarkeit prüfen

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial

Journal of bone and mineral research, 2022-10, Vol.37 (10), p.1891-1902

2022

Link zum Volltext

Verfügbarkeit prüfen

Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation

Orphanet journal of rare diseases, 2013-12, Vol.8 (1), p.190-190, Article 190

2013

Link zum Volltext

Verfügbarkeit prüfen

Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells

Nature (London), 2014-03, Vol.507 (7490), p.99-103

2014

Link zum Volltext

Verfügbarkeit prüfen

Virtual Interviews at Graduate Medical Education Training Programs: Determining Evidence-Based Best Practices

Academic medicine, 2021-08, Vol.96 (8), p.1137-1145

2021

Link zum Volltext

Verfügbarkeit prüfen

Long term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva

Rheumatology (Oxford, England), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes

Orphanet journal of rare diseases, 2019-05, Vol.14 (1), p.98-98, Article 98

2019

Link zum Volltext

Verfügbarkeit prüfen

Sirtuin-3 Promotes Adipogenesis, Osteoclastogenesis, and Bone Loss in Aging Male Mice

Endocrinology (Philadelphia), 2017-09, Vol.158 (9), p.2741-2753

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 454

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(401)
Mit Volltextzugriff
(420)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(453)
Japanisch
(57)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(267)
Life Sciences & Biomedicine
(182)
Humans
(164)
Male
(89)
Female
(72)
Animals
(50)
Adult
(47)
Physical Sciences
(47)
Aged
(42)
Technology
(41)
Middle Aged
(40)
Mice
(34)
Fibrodysplasia Ossificans Progressiva
(31)
Mutation
(29)
Patients
(29)
Endocrinology & Metabolism
(26)
Engineering
(26)
Physics
(26)
Oncology
(24)
Heterotopic Ossification
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche

Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva

Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization

Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva

Reduction of New Heterotopic Ossification (HO) in the Open‐Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP)

A follow-up report on the published paper Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva

Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory

Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification

Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva

A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy

Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages

Immunologic Aspects in Fibrodysplasia Ossificans Progressiva

Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors

MicroRNA regulation of cell lineages in mouse and human embryonic stem cells

BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence

Improving care pathways for people living with rare bone diseases (RBDs): outcomes from the first RBD Summit

Identification of Risk Factors in the Development of Heterotopic Ossification after Primary Total Hip Arthroplasty

Using Human Induced Pluripotent Stem Cells to Model Skeletal Diseases

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial

Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation

Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells

Virtual Interviews at Graduate Medical Education Training Programs: Determining Evidence-Based Best Practices

Long term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva

Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes

Sirtuin-3 Promotes Adipogenesis, Osteoclastogenesis, and Bone Loss in Aging Male Mice

Suchergebnisse filtern